# Braintree Laboratories clinical trials: 49 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 49 trials with Braintree Laboratories as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Braintree Laboratories: 49 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/braintree-laboratories

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 49
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 49, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 5, 2023 | NCT05890001 | A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease | Braintree Laboratories | Phase 3 | Completed | Non-erosive Reflux Disease, Erosive Esophagitis | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05890001) |
| October 20, 2022 | NCT05587322 | A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease | Braintree Laboratories | Phase 3 | Completed | Non-erosive Reflux Disease | 788 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05587322) |
| October 20, 2022 | NCT05587309 | A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis | Braintree Laboratories | Phase 3 | Completed | Erosive Esophagitis | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05587309) |
| June 24, 2020 | NCT04446312 | Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy | Braintree Laboratories | Phase 3 | Completed | Colonoscopy | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04446312) |
| June 24, 2020 | NCT04446299 | Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy | Braintree Laboratories | Phase 3 | Completed | Colonoscopy | 519 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04446299) |
| January 2, 2020 | NCT04214301 | An Open-Label Preference Evaluation of BLI800 | Braintree Laboratories | Phase 4 | Completed | Colonoscopy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04214301) |
| January 19, 2018 | NCT03404401 | A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy | Braintree Laboratories | Phase 3 | Completed | Colonoscopy | 620 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03404401) |
| November 1, 2017 | NCT03328507 | A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects | Braintree Laboratories | Phase 2 | Completed | Colonoscopy | 121 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03328507) |
| August 25, 2017 | NCT03261960 | A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy | Braintree Laboratories | Phase 3 | Completed | Colonoscopy | 389 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03261960) |
| April 6, 2017 | NCT03103581 | BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects | Braintree Laboratories | Phase 2 | Completed | Colonoscopy | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03103581) |
| January 18, 2017 | NCT03023085 | A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects | Braintree Laboratories | Phase 1/2 | Completed | Colonoscopy | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03023085) |
| July 4, 2016 | NCT02822508 | A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation | Braintree Laboratories | Phase 2/3 | Completed | Constipation | 434 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02822508) |
| July 1, 2016 | NCT02820714 | A Pilot Study of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation | Braintree Laboratories | Phase 2 | Completed | Constipation | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02820714) |
| June 30, 2016 | NCT02819323 | A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy | Braintree Laboratories | Phase 3 | Completed | Colonoscopy | 91 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02819323) |
| June 30, 2016 | NCT02819310 | An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults | Braintree Laboratories | Phase 3 | Completed | Constipation, Chronic Idiopathic Constipation, CIC | 330 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02819310) |
| June 30, 2016 | NCT02819297 | BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults | Braintree Laboratories | Phase 3 | Completed | Constipation, Chronic Idiopathic Constipation, CIC | 1,020 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02819297) |
| January 28, 2016 | NCT02665728 | A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects | Braintree Laboratories | Phase 2 | Completed | Constipation | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02665728) |
| November 13, 2015 | NCT02604680 | A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris | Braintree Laboratories | Phase 2 | Completed | Acne Vulgaris | 509 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02604680) |
| June 25, 2015 | NCT02481947 | A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults | Braintree Laboratories | Phase 3 | Completed | Chronic Idiopathic Constipation | 459 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02481947) |
| March 3, 2015 | NCT02376465 | A Pilot Evaluation of an Experimental BLI4600 Formulation for Bowel Preparation in Adult Patients Undergoing Colonoscopy | Braintree Laboratories | Phase 2 | Completed | Bowel Preparation for Colonoscopy | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02376465) |
| July 15, 2014 | NCT02189850 | Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy | Braintree Laboratories | Phase 2 | Completed | Colonoscopy | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02189850) |
| March 21, 2013 | NCT01815450 | BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris | Braintree Laboratories | Phase 2 | Completed | Acne Vulgaris | 369 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01815450) |
| February 8, 2013 | NCT01786629 | BLI800-480: A Safety and Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects | Braintree Laboratories | Phase 4 | Completed | Colonoscopy, Bowel Preparation, Endoscopy | 338 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01786629) |
| September 19, 2012 | NCT01687985 | A Safety and Efficacy Evaluation of BLI801 Laxative in Constipated Adults | Braintree Laboratories | Phase 2 | Completed | Constipation | 81 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01687985) |
| December 29, 2011 | NCT01501513 | A Safety Study of 3 Different Bowel Cleansing Preparations | Braintree Laboratories | Phase 3 | Completed | Colonoscopy, Bowel Preparation, Endoscopy | 541 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01501513) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1/2 | 2 |
| Phase 2 | 13 |
| Phase 2/3 | 1 |
| Phase 3 | 20 |
| Phase 4 | 13 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 48 |
| Terminated | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Constipation | 15 |
| Acne Vulgaris | 3 |
| Non-Erosive Reflux Disease | 2 |
| Colonic Neoplasms | 2 |
| Gastroesophageal Reflux | 1 |
| Heartburn | 1 |
| Crohn Disease | 1 |
| Inflammatory Bowel Diseases | 1 |
| Fistula | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Laboratories in the United States](https://specstream.ai/data/businesses/laboratories/united-states)
- [Vending machine suppliers in the United States](https://specstream.ai/data/businesses/vending-machine-suppliers/united-states)
- [Ophthalmology practices in the United States](https://specstream.ai/data/businesses/ophthalmology-practices/united-states)
- [Exporters in the United States](https://specstream.ai/data/businesses/exporters/united-states)
- [Automotive companies in the United States](https://specstream.ai/data/businesses/automotive-companies/united-states)
- [Public adjusters in the United States](https://specstream.ai/data/businesses/public-adjusters/united-states)
